Benefits and risks of implantable cardioverter-defibrillators in children and young adults with congenital heart disease, primary electrical disease or paediatric cardiomyopathy
The high rate of appropriate therapies underscores the critical importance of risk assessment in ICD selection, particularly to mitigate lead failures and unnecessary shocks. However, defibrillator therapy has a relevant rate of unplanned surgeries, with abdominal generators and epicardial/extracardiac leads being risk factors.
Authors
- Masamichi Ono (ORCID: https://orcid.org/0000-0001-5699-6394)
- Alfred Hager (ORCID: https://orcid.org/0000-0002-2481-2017)
- Muneaki Matsubara (ORCID: https://orcid.org/0000-0001-7163-2724)
- Jonas Palm (ORCID: https://orcid.org/0000-0003-1952-0631)
- Carsten Lennerz (ORCID: https://orcid.org/0000-0002-1693-6474)
- Lena Friedrich (ORCID: https://orcid.org/0000-0003-4263-6237)
- Thibault Schaeffer (ORCID: https://orcid.org/0000-0001-6842-2988)
- Carolin Niedermaier (ORCID: https://orcid.org/0009-0005-2354-868X)
- Andrei Fetcu
- Paul Philipp Heinisch (ORCID: https://orcid.org/0000-0003-4061-4499)
- Takuya Osawa (ORCID: https://orcid.org/0000-0002-6461-6344)
- Peter Ewert
- Jürgen Hörer (ORCID: https://orcid.org/0000-0002-2716-1424)
Institutions
- Deutsches Herzzentrum München (DE)
- Technical University of Munich (DE)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- European Journal of Cardio-Thoracic Surgery
- Published
- 2025-03-28
- DOI
- https://doi.org/10.1093/ejcts/ezaf134
- Citations
- 1
- Primary Topic
- Cardiac pacing and defibrillation studies
- Type
- article
- Field-Weighted Citation Impact
- 1.39